ID23188A - Garam tartrat dari dipeptida tersubstitusi sebagai sekretagogum hormon pertumbuhan - Google Patents

Garam tartrat dari dipeptida tersubstitusi sebagai sekretagogum hormon pertumbuhan

Info

Publication number: ID23188A
Authority: ID; Indonesia
Prior art keywords: secretagogum; dipeped; substituted; growth hormone; tartrate
Prior art date: 1997-06-25

Application number

IDW991663A

Other languages

English (en)

Indonesian (id)

Inventor

Plipi Albert Carpino

Paul Andrew Dasilva Jardine

Bruce Allen Lefker

Jerry Anthony Murry

Original Assignee

Prizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-25

Filing date

1998-06-05

Publication date

2000-03-23

1998-06-05 Application filed by Prizer Products Inc filed Critical Prizer Products Inc

2000-03-23 Publication of ID23188A publication Critical patent/ID23188A/id

Links

FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 title 1
102000018997 Growth Hormone Human genes 0.000 title 1
108010051696 Growth Hormone Proteins 0.000 title 1
239000000122 growth hormone Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
229940095064 tartrate Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Hematology (AREA)
Crystallography & Structural Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)

IDW991663A 1997-06-25 1998-06-05 Garam tartrat dari dipeptida tersubstitusi sebagai sekretagogum hormon pertumbuhan ID23188A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5072397P	1997-06-25	1997-06-25

Publications (1)

Publication Number	Publication Date
ID23188A true ID23188A (id)	2000-03-23

Family

ID=21966996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991663A ID23188A (id)	1997-06-25	1998-06-05	Garam tartrat dari dipeptida tersubstitusi sebagai sekretagogum hormon pertumbuhan

Country Status (40)

Country	Link
US (2)	US6248717B1 (fr)
EP (1)	EP0989993B1 (fr)
JP (1)	JP3414759B2 (fr)
KR (1)	KR100339936B1 (fr)
CN (2)	CN1314912A (fr)
AP (1)	AP1043A (fr)
AR (1)	AR012255A1 (fr)
AT (1)	ATE388163T1 (fr)
AU (1)	AU744775B2 (fr)
BG (1)	BG104024A (fr)
BR (1)	BR9810623B1 (fr)
CA (1)	CA2294422C (fr)
CO (1)	CO4810383A1 (fr)
DE (1)	DE69839211T2 (fr)
DK (1)	DK0989993T3 (fr)
DZ (1)	DZ2538A1 (fr)
EA (1)	EA002643B1 (fr)
ES (1)	ES2301196T3 (fr)
GT (1)	GT199800085A (fr)
HR (1)	HRP980362A2 (fr)
HU (1)	HUP0002664A3 (fr)
ID (1)	ID23188A (fr)
IL (1)	IL132810A0 (fr)
IS (1)	IS5276A (fr)
MA (1)	MA26516A1 (fr)
NO (1)	NO996469L (fr)
NZ (1)	NZ500658A (fr)
OA (1)	OA11241A (fr)
PA (1)	PA8453401A1 (fr)
PE (1)	PE97599A1 (fr)
PL (1)	PL337654A1 (fr)
PT (1)	PT989993E (fr)
SK (1)	SK177299A3 (fr)
TN (1)	TNSN98111A1 (fr)
TR (1)	TR199903261T2 (fr)
TW (1)	TWI221153B (fr)
UA (1)	UA53716C2 (fr)
UY (1)	UY25059A1 (fr)
WO (1)	WO1998058948A1 (fr)
ZA (1)	ZA985541B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
US6465445B1 (en) *	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6380184B1 (en)	1998-10-28	2002-04-30	Bristol-Myers Squibb Co.	Benzoazepines and analogs thereof useful as growth hormone secretagogues
WO2000048623A1 (fr)	1999-02-18	2000-08-24	Kaken Pharmaceutical Co., Ltd.	Nouveaux derives amide secretagogues de l'hormone de croissance
US6541634B2 (en) *	1999-02-26	2003-04-01	Pfizer Inc.	Process for preparing growth hormone secretagogues
US6525203B1 (en)	1999-03-12	2003-02-25	Bristol-Myers Squibb Company	Heterocyclic aromatic compounds useful as growth hormone secretagogues
US6518292B1 (en)	1999-03-12	2003-02-11	Bristol-Myers Squibb Co.	Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US20020013327A1 (en) *	2000-04-18	2002-01-31	Lee Andrew G.	Compositions and methods for treating female sexual dysfunction
JP2004507456A (ja)	2000-05-11	2004-03-11	ブリストル−マイヤーズ　スクイブ　カンパニー	成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
AU2001264977B2 (en)	2000-05-30	2005-04-14	Merck & Co., Inc.	Melanocortin receptor agonists
ATE446758T1 (de) *	2000-05-31	2009-11-15	Pfizer Prod Inc	Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
IL143690A0 (en) *	2000-06-19	2002-04-21	Pfizer Prod Inc	The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
EP1181933A3 (fr) *	2000-06-29	2002-04-10	Pfizer Products Inc.	Utilisation d'un secretagogue de l'hormone de croissance comme comme inducteur de la faim
IL143942A0 (en) *	2000-06-29	2002-04-21	Pfizer Prod Inc	Use of growth hormone secretagogues for treatment of physical performance decline
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
MXPA03001771A (es) *	2000-08-30	2003-06-04	Pfizer Prod Inc	Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
IL145540A0 (en) *	2000-09-28	2002-06-30	Pfizer Prod Inc	Use of growth hormone secretagogues in conjunction with physical exercise
HUP0301351A3 (en) *	2000-10-13	2007-05-29	Lilly Co Eli	Use of substituted dipeptides as growth hormone secretagogues, process for their preparation and pharmaceutical compositions containing them
CA2372450A1 (fr) *	2001-05-10	2001-09-19	Pharmaceutical Partners Of Canada Inc.	Preparation injectable liquide de pamidronate disodique
US7125840B2 (en)	2001-10-09	2006-10-24	Eli Lilly And Company	Substituted dipeptides as growth hormone secretagogues
WO2003041641A2 (fr)	2001-11-09	2003-05-22	Bristol-Myers Squibb Company	Analogues de tetrahydroisoquinoline utiles comme modulateurs de l'activite du recepteur des chimiokines
WO2003087069A2 (fr)	2002-04-09	2003-10-23	Eli Lilly And Company	Secretagogues d'hormone de croissance
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2005027913A1 (fr) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Compositions pharmaceutiques et methodes de traitement consistant en des associations d'un derive de la 2-alkylidene-19-nor-vitamine d et d'un secretagogue de l'hormone de croissance
WO2005097788A2 (fr) *	2004-04-02	2005-10-20	Elixir Pharmaceuticals, Inc.	Sulfonamides et utilisations de ceux-ci
KR100641571B1 (ko) *	2005-01-05	2006-10-31	주식회사 팬택앤큐리텔	이동통신 단말기에서의 클럭 발생 장치
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CA2677399C (fr)	2007-02-09	2016-09-13	Tranzyme Pharma, Inc.	Modulateurs macrocycliques du recepteur de la ghreline et leurs procedes d'utilisation
US8377863B2 (en) *	2007-05-29	2013-02-19	Unigene Laboratories Inc.	Peptide pharmaceutical for oral delivery
CN103717610A (zh) *	2011-06-16	2014-04-09	隆沙有限公司	萃取胜肽的方法及其在液相胜肽合成的应用
CA2856030A1 (fr) *	2011-11-16	2013-05-23	Duke University	Compositions de biphosphonates et methodes de traitement et/ou de reduction du dysfonctionnement cardiaque
US9119832B2 (en)	2014-02-05	2015-09-01	The Regents Of The University Of California	Methods of treating mild brain injury
JP6910950B2 (ja)	2015-01-12	2021-07-28	エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓＢｉｏｐｈａｒｍａ，Ｉｎｃ．	固形経口剤形
WO2017075535A1 (fr)	2015-10-28	2017-05-04	Oxeia Biopharmaceuticals, Inc.	Méthodes de traitement de troubles neurodégénératifs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4411890A (en)	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
CA2147503A1 (fr)	1992-11-06	1994-05-26	Judith M. Pisano	Analogues de dipeptides substitues stimulant la liberation de l'hormone de croissance
WO1994013696A1 (fr)	1992-12-11	1994-06-23	Merck & Co., Inc.	Spiro-piperidines et homologues favorisant la liberation de l'hormone de croissance
CN1174504A (zh) *	1993-11-09	1998-02-25	麦克公司	促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
GT199800127A (es)	1997-08-29	2000-02-01		Combinaciones terapeuticas.

1998
- 1998-05-06 UA UA99127067A patent/UA53716C2/uk unknown
- 1998-06-05 CA CA002294422A patent/CA2294422C/fr not_active Expired - Lifetime
- 1998-06-05 PT PT98921681T patent/PT989993E/pt unknown
- 1998-06-05 KR KR1019997012222A patent/KR100339936B1/ko not_active Expired - Fee Related
- 1998-06-05 AU AU74455/98A patent/AU744775B2/en not_active Ceased
- 1998-06-05 ES ES98921681T patent/ES2301196T3/es not_active Expired - Lifetime
- 1998-06-05 TR TR1999/03261T patent/TR199903261T2/xx unknown
- 1998-06-05 ID IDW991663A patent/ID23188A/id unknown
- 1998-06-05 AT AT98921681T patent/ATE388163T1/de not_active IP Right Cessation
- 1998-06-05 HU HU0002664A patent/HUP0002664A3/hu unknown
- 1998-06-05 NZ NZ500658A patent/NZ500658A/en unknown
- 1998-06-05 CN CN98806559A patent/CN1314912A/zh active Pending
- 1998-06-05 EP EP98921681A patent/EP0989993B1/fr not_active Expired - Lifetime
- 1998-06-05 PL PL98337654A patent/PL337654A1/xx unknown
- 1998-06-05 US US09/380,886 patent/US6248717B1/en not_active Expired - Lifetime
- 1998-06-05 SK SK1772-99A patent/SK177299A3/sk unknown
- 1998-06-05 BR BRPI9810623-6A patent/BR9810623B1/pt not_active IP Right Cessation
- 1998-06-05 DK DK98921681T patent/DK0989993T3/da active
- 1998-06-05 JP JP50402799A patent/JP3414759B2/ja not_active Expired - Fee Related
- 1998-06-05 CN CNA2004100059410A patent/CN1524857A/zh active Pending
- 1998-06-05 DE DE69839211T patent/DE69839211T2/de not_active Expired - Lifetime
- 1998-06-05 WO PCT/IB1998/000874 patent/WO1998058948A1/fr not_active Ceased
- 1998-06-05 IL IL13281098A patent/IL132810A0/xx unknown
- 1998-06-05 EA EA199901076A patent/EA002643B1/ru not_active IP Right Cessation
- 1998-06-11 PA PA19988453401A patent/PA8453401A1/es unknown
- 1998-06-18 GT GT199800085A patent/GT199800085A/es unknown
- 1998-06-18 AP APAP/P/1998/001266A patent/AP1043A/en active
- 1998-06-19 PE PE1998000540A patent/PE97599A1/es not_active Application Discontinuation
- 1998-06-22 TW TW087110024A patent/TWI221153B/zh not_active IP Right Cessation
- 1998-06-23 AR ARP980103022A patent/AR012255A1/es not_active Application Discontinuation
- 1998-06-23 UY UY25059A patent/UY25059A1/es not_active IP Right Cessation
- 1998-06-24 TN TNTNSN98111A patent/TNSN98111A1/fr unknown
- 1998-06-24 MA MA25138A patent/MA26516A1/fr unknown
- 1998-06-24 DZ DZ980148A patent/DZ2538A1/fr active
- 1998-06-25 HR HR60/050,723A patent/HRP980362A2/hr not_active Application Discontinuation
- 1998-06-25 CO CO98036378A patent/CO4810383A1/es unknown
- 1998-06-25 ZA ZA9805541A patent/ZA985541B/xx unknown
1999
- 1999-11-26 IS IS5276A patent/IS5276A/is unknown
- 1999-12-16 BG BG104024A patent/BG104024A/bg unknown
- 1999-12-21 OA OA9900299A patent/OA11241A/en unknown
- 1999-12-23 NO NO996469A patent/NO996469L/no not_active Application Discontinuation
2000
- 2000-12-11 US US09/734,269 patent/US6596867B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BG104024A (bg)	2000-07-31
GT199800085A (es)	1999-12-10
DE69839211T2 (de)	2009-03-19
EA002643B1 (ru)	2002-08-29
JP3414759B2 (ja)	2003-06-09
WO1998058948A1 (fr)	1998-12-30
TR199903261T2 (xx)	2000-08-21
US20010016570A1 (en)	2001-08-23
NO996469D0 (no)	1999-12-23
US6248717B1 (en)	2001-06-19
DE69839211D1 (de)	2008-04-17
IL132810A0 (en)	2001-03-19
CA2294422C (fr)	2003-07-22
UY25059A1 (es)	2000-12-29
ZA985541B (en)	2000-01-10
OA11241A (en)	2003-05-26
MA26516A1 (fr)	2004-12-20
IS5276A (is)	1999-11-26
JP2000514840A (ja)	2000-11-07
CA2294422A1 (fr)	1998-12-30
ATE388163T1 (de)	2008-03-15
US6596867B2 (en)	2003-07-22
UA53716C2 (uk)	2003-02-17
AU7445598A (en)	1999-01-04
DK0989993T3 (da)	2008-06-02
BR9810623B1 (pt)	2010-06-15
HRP980362A2 (en)	1999-02-28
KR20010014153A (ko)	2001-02-26
DZ2538A1 (fr)	2003-02-08
AP1043A (en)	2002-02-04
PA8453401A1 (es)	2000-05-24
EA199901076A1 (ru)	2000-08-28
HUP0002664A2 (hu)	2000-12-28
EP0989993B1 (fr)	2008-03-05
CO4810383A1 (es)	1999-06-30
AU744775B2 (en)	2002-03-07
CN1314912A (zh)	2001-09-26
EP0989993A1 (fr)	2000-04-05
AP9801266A0 (en)	1998-06-30
HUP0002664A3 (en)	2001-12-28
TNSN98111A1 (fr)	2005-03-15
NZ500658A (en)	2001-08-31
AR012255A1 (es)	2000-09-27
TWI221153B (en)	2004-09-21
PE97599A1 (es)	1999-10-12
NO996469L (no)	2000-02-23
ES2301196T3 (es)	2008-06-16
PL337654A1 (en)	2000-08-28
SK177299A3 (en)	2001-09-11
PT989993E (pt)	2008-04-15
CN1524857A (zh)	2004-09-01
KR100339936B1 (ko)	2002-06-10
BR9810623A (pt)	2000-07-25

Publication	Publication Date	Title
DK0989993T3 (da)	2008-06-02	Tartratsalt af et substitueret depeptid som væksthormon sekretagog
IS5378A (is)	2000-02-18	Apríl-nýstárlegt prótín sem hefur áhrif á vöxt
ID18218A (id)	1998-03-19	Senyawa dengan sifat-sifat pelepas hormon pertumbuhan
DE69800491D1 (de)	2001-02-22	Baumschere
EP0913086A4 (fr)	2000-03-29	Leurre
DE69815745D1 (de)	2003-07-31	Angelrolle
PT926158E (pt)	2003-11-28	Hormona paratiroide cristalina
DE60035376D1 (de)	2007-08-09	Schädlingsbekämpfung
IL149283A0 (en)	2002-11-10	Decoy
ID21198A (id)	1999-05-06	Bagian yang dikait dari pengancing mekanik
AU141010S (en)	2000-06-27	Insect control lantern
ID17664A (id)	1998-01-15	Pembuatan kaprolaktam dari 6-aminokapronitril
DE69813161D1 (de)	2003-05-15	Angelhaken
NO20003694D0 (no)	2000-07-19	VLA-4 antagonister
ID27651A (id)	2001-04-19	Pembuatan berlanjut poliamida dari aminonitril
FR2791348B1 (fr)	2007-10-05	POLYPEPTIDE Npt2B
DK1047618T3 (da)	2004-09-20	Trådnetstransportbånd
DK1230369T3 (da)	2008-03-31	Polypeptidhormon phosphatonin
DK1079690T3 (da)	2004-05-17	Skadedyrsstyring
NL1010255A1 (nl)	1999-04-08	Bollenplanter.
ID18964A (id)	1998-05-28	Garam-garam dimesilat dari ligan-ligan neuropeptida y
GB2355638B (en)	2003-07-09	Horticultural aid
DE69815513D1 (de)	2003-07-17	Photoperiodische wachstumsregelung
KR980000103U (ko)	1998-03-30	자라사육기
NL1010075A1 (nl)	1999-04-28	Tuinberging.